腹腔镜下卵巢囊肿剥除手术电凝和缝合两种止血方法对卵巢功能的影响

分析腹腔镜下卵巢囊肿剥除手术电凝和缝合两种止血方法对卵巢功能的影响。收集采用腹腔镜下卵巢囊肿剥除手术治疗的140例患者作为研究对象,根据止血方法将其分为缝合止血组与电凝止血组各70例,电凝止血组在术中剥除卵巢囊肿后实施电凝止血,缝合止血组在术中剥除卵巢囊肿后实施缝合止血,采集手术前后的空腹静脉血查FSH(卵泡刺激素)、LH(黄体生成素)、E2(血清雌二醇)变化幅度。缝合止血组手术后卵泡刺激素、黄体生成素、血清雌二醇等变化幅度明显小于电凝止血组(P<0.05)。在开展腹腔镜下卵巢囊肿剥除手术过程中对患者实施缝合止血能有效减轻对卵巢功能的影响。     

腹腔镜下卵巢瘤剥除后单极、双极电凝止血和缝合止血的临床效果比较

目的比较腹腔镜下卵巢瘤剥除后单极、双极电凝止血和缝合止血的临床效果。方法回顾性分析我院2018年6月～2019年6月行腹腔镜下卵巢瘤剥除术治疗的90例患者临床资料,将应用单极电凝止血的30例患者临床资料归为单极组,应用双极电凝止血的30例患者临床资料归为双极组,应用缝合止血的30例患者临床资料归为缝合组,比较三组手术时间、术中出血量及卵巢功能指标。结果缝合组手术时间长于电凝组,术中出血量短于电凝组,双极组的手术时间、出血量少于单极组,差异均有统计学意义(P<0.05);术后3月,缝合组黄体生成素(LH)、促卵泡激素(FSH)含量、窦卵泡数(AFC)低于双极组,雌二醇(E2)高于双极组,且双极组LH、FSH、AFC低于单极组,E2高于单极组,差异均有统计学意义(P<0.05)。结论与电凝止血比较,腹腔镜下卵巢瘤剥除术中行缝合止血的效果更为显著,双极止血效果优于单极止血效果,且缝合止血卵巢功能的影响最小,单极止血对卵巢功能影响最大。     

腹腔镜卵巢囊肿剥除术中采取不同止血方式对患者术中出血量及卵巢功能的影响

目的:观察不同止血方式在腹腔镜卵巢囊肿剥除术中对患者出血量及卵巢功能的影响。方法:选取2017年6月～2018年12月收治的卵巢囊肿患者80例作为研究对象,依据随机对照原则分为对照组与观察组,各40例。两组患者均行腹腔镜卵巢囊肿剥除术,对照组术中行缝合止血,观察组则行双极电凝止血,比较两组患者临床指标、卵巢功能指标以及并发症发生情况。结果:观察组手术时间、术后下床活动时间及住院时间短于对照组,术中出血量少于对照组,差异具有统计学意义(P0.05);两组术前促卵泡激素、雌二醇、黄体生成素比较,差异无统计学意义(P0.05);观察组术后促卵泡激素、黄体生成素高于对照组,雌二醇低于对照组,差异具有统计学意义(P0.05);观察组术后并发症发生率低于对照组,差异具有统计学意义(P0.05)。结论:腹腔镜卵巢囊肿剥除术中采取双极电凝止血方式,可降低术中出血量,减少并发症,有效保持卵巢的正常生理功能,利于患者恢复。     

腹腔镜良性卵巢囊肿剥除术对卵巢功能的影响

目的：探讨腹腔镜卵巢囊肿剥除术中使用单、双极电凝及缝合对卵巢功能的影响。方法：137例单侧卵巢良性囊肿患者,均行腹腔镜下卵巢囊肿剥除术,按不同的止血方法,将患者分为3组：单极电凝组40例、双极电凝组50例、镜下缝合组47例,分别于术前、术后3个月、术后6个月的月经第3天抽空腹血检测雌二醇（E2）、促卵泡激素（FSH）,并经阴道超声计数窦卵泡数。结果：3组病例术后3个月较术前均出现E2水平下降和FSH水平增高,窦卵泡数减少,其中单极电凝组和双极电凝组分别与术前比较有显著性差异（P〈0.05）。与镜下缝合组比较,单极电凝组和双极电凝组术后窦卵泡数以及E2、FSH均有显著差异（P〈0.05）。术后3个月双极电凝组的E2较单极电凝组高,有显著差异（P〈0.05）;术后6个月两组的E2较术后3个月增高,也有显著差异（P〈0.05）,但窦卵泡数术后6个月较术后3个月无显著差异。结论：腹腔镜下卵巢囊肿剥除创面采用电凝止血会引起对卵巢功能的损害,而使用镜下缝合止血可更好地保留其功能。     

腹腔镜卵巢囊肿剥除术中单极电凝止血对卵巢功能的影响观察

选取2010年5月~2014年5月我院收治的135例腹腔镜卵巢囊肿患者。按止血方法的不同分为单极电凝止血组、镜下缝合组、超声刀组各45例。比较三组患者术前、术后3个月、术后6个月激素(E2、LH、FSH)水平的变化、围绝经期综合征发生率、月经紊乱情况。结果单极电凝止血组患者围绝经期综合征发生率高于镜下缝合组、超声刀组患者(P<0.05);单极电凝止血组患者月经紊乱的发生率高于镜下缝合组、超声刀组患者(P<0.05)。在行腹腔镜卵巢囊肿剥除术中,单极电凝止血方式对卵巢功能具有一定的损害,可降低E2水平,升高FSH、LH水平,增加患者发生围绝经期综合征与月经紊乱的可能。     

腹腔镜卵巢囊肿剥除术不同止血方式对卵巢功能的近期影响研究

目的比较不同止血方式对腹腔镜下卵巢囊肿剥除术后患者卵巢近期功能的影响。方法随机将2011年12月至2013年12月在济源市妇幼保健院进行腹腔镜卵巢囊肿剥除术的92例患者分为治疗组与对照组两组,每组46例。治疗组采取镜下缝合止血,对照组采取单极电凝止血。比较两组患者术前1个月、术后1个月、术后3个月的性激素水平。结果两组患者术前各项性激素水平比较差异未见统计学意义(P0.05)。治疗组术后1个月及3个月雌二醇、孕酮、睾酮水平略有下降,卵泡刺激素及促黄体生成素略有升高,但与术前比较差异未见统计学意义(P0.05)。而对照组术后1个月及3个月的雌二醇、孕酮、睾酮水平明显下降,卵泡刺激素及促黄体生成素明显升高,与术前相比差异有统计学意义(P0.01)。结论腹腔镜下卵巢囊肿剥除术采取镜下缝合止血对卵巢功能的影响较小,可在临床中推广应用。     

腹腔镜卵巢囊肿剔除术止血方式对卵巢功能影响

目的:探讨腹腔镜卵巢囊肿别除术不同止血方式对患者卵巢功能的影响.方法:腹腔镜卵巢囊肿剔除术患者124例,依据术中止血方式不同分为2组,观察组62例术中应用传统方法缝合止血,对照组62例应用双极电凝钳止血.比较2组术前,术后第2,6个月卵泡刺激素、黄体生成素、雌二醇水平及卵泡数和卵巢功能衰退发生率.结果:观察组术后第2,6个月卵泡刺激素、黄体生成素,雌二醇水平、卵泡数与术前比较差异无统计学意义(P>0.05),对照组术后第2,6个月卵泡刺激素水平及卵泡数与术前比较差异有统计学意义(P<0.05),术后第6个月黄体生成素、雌二醇水平与术前比较差异有统计学意义(P<0.05).结论:腹腔镜下卵巢囊肿剔除术应用传统止血方法对卵巢功能影响较小.     

腹腔镜卵巢囊肿剥除术中止血方法的选择对卵巢功能的影响

目的探讨腹腔镜卵巢囊肿剥除术中使用不同止血方法对卵巢功能的影响。方法选择120例单侧卵巢良性肿瘤患者行腹腔镜卵巢囊肿剥除术，并分为4组：超声刀组、单极电凝组、双极电凝组、缝合组，每组30例。于术前、术后3个月和6个月抽血检测E2、FSH、LH，并术后随访。结果单，双极电凝组术后发生月经改变及围绝经期综合征明显多于超声刀组和缝合组（P〈0．05）。四组术后3个月和6个月较术前均出现E2下降和FSH、LH增高，其中单、双极电凝组分别与术前比较差异有统计学意义（P〈0．05）。此两组分别与超声刀组和缝合组术后E2、FSH、LH的比较差异有统计学意义（P〈0．05）。双极电凝组术后3个月的E2较单极电凝组明显偏高（P〈0．05），该两组的E2术后6个月较术后3个月显著增高（P〈0．05）。结论腹腔镜下卵巢囊肿剥除创面采用电凝止血会引起卵巢功能的损害，而使用镜下缝合或超声刀止血可更好地保留其功能。     

卵巢良性囊肿剔除术止血方式对女性卵巢功能的影响

目的探讨卵巢囊肿剔除术不同止血方式对育龄女性卵巢功能及生存质量的近期影响。方法卵巢良性囊肿剔除术患者138例,按不同止血方式分为3组：A组46例应用腹腔镜缝合止血、B组46例应用腹腔镜电凝止血、C组46例应用经腹缝合止血。比较术前1个月、术后6个月卵泡刺激素、促黄体生成素和雌二醇水平。结果 A组术后6个月卵泡刺激素、促黄体生成素和雌二醇水平较术前比较,差异无统计学意义（P〉0.05）。B组及C组术后6个月血清卵泡刺激素、促黄体生成素较术前明显增高,雌二醇水平明显降低,差异有统计学意义（P〈0.05）。结论卵巢囊肿剔除术应用腹腔镜下缝合止血对育龄女性卵巢功能的近期影响较小。     

腹腔镜卵巢囊肿剥除术中单极电凝止血对卵巢功能的影响

目的探讨腹腔镜卵巢囊肿剥除术中单极电凝止血对卵巢功能的影响。方法入院的150例单侧卵巢囊肿患者按照抽签方法随机地均分为三组,即超声刀组50例、镜下缝合组50例及单极电凝组50例。比较三组术前、术后2个月及术后4个月月经改变情况、围绝经期综合征发生情况及激素(E2、FSH)水平。结果 (1)单极电凝组患者术后月经改变例数均显著大于超声刀组与镜下缝合组(P0.05);(2)单极电凝组患者围绝经期综合征发生率均显著大于超声刀组与镜下缝合组(P0.05);(3)单极电凝组患者术后与术前相比,出现E2水平降低与FSH升高,差异有统计学意义(P0.05),且与超声刀组及镜下缝合组患者的E2、FSH水平相比,差异均有统计学意义(P0.05)。结论单极电凝止血会对卵巢功能造成一定的损害。     

Ovarian cancer

Ovarian cancer is the leading cause of death from gynecologic cancers. Although approximately 2,400 women are diagnosed each year in Canada, most women know little about the disease. While it is not common, ovarian cancer is a devastating diagnosis. The symptoms of ovarian cancer are non-specific and there is no effective screening tool. Surgery, chemotherapy and radiation given alone or in combination are most commonly used to treat ovarian cancer. Surgery can result in premature menopause for women in their child-bearing years. Chemotherapy may cause a multiplicity of distressing side-effects. Women with ovarian cancer are living longer and with an improved quality of life. Nurses are in a key position to increase awareness and provide support and information about coping with the disease and side-effects of treatment.     

Ovarian cancer

OBJECTIVES: To review the progress in the management of ovarian cancer in the last decade and future directions. DATA SOURCES: Research studies, review articles, and abstracts. CONCLUSIONS: There is an increased understanding of ovarian cancer biology, the genetic basis for hereditary ovarian cancer, staging and the role of cytoreductive surgery, and more effective chemotherapy, resulting in an increase in the percentage of patients who will live 5 years from the time of diagnosis. IMPLICATIONS FOR NURSING PRACTICE: The nurse can play an invaluable role as the options of treatment are considered and weighed against quality-of-life considerations.     

Ovarian cancer

Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival. The hope of new drug therapy, such as cisplatin-taxol regimens, intraperitoneal therapy, immunotherapy, and bone marrow transplantation, needs further investigation to become reality. As new and potentially more toxic regimens are developed, the nurse must be knowledgeable about the therapies and adverse effects, and maintain a high level of clinical expertise in order to teach the patient, reinforce information, clarify misconceptions, and provide the patient with supportive physical and emotional care.     

Ovarian malignancies

Ovarian cancer is the second most common pelvic tumor and the leading cause of death from a gynecologic malignancy. MRI plays a strategic role in patient care for initial evaluation and treatment planning in patients with ovarian cancer. This article reviews the pathologic classification and characteristic findings on MRI of ovarian malignancies, patterns of tumor spread and staging, and the utility of cross-sectional imaging prior to primary and secondary to cytoreproductive surgery.